Search
Myriad Genetics Inc
MYGNAdd to Watchlist
4.250USD
0.0000.00%
Close 06/16, 16:00（ET）Quotes delayed by 15 min
401.20MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-06-16 The current financial score of Myriad Genetics Inc is 7.25, ranking 93 out of 203 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 200.40M, representing a year-over-year increase of 2.30%, while its net profit experienced a year-over-year increase of 34000.00%.
Financials
7.93
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.06
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
7.97
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
6.11
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.18
Free cash flow
Relevant data have not been disclosed by the company yet.
